Tiejun Li

Title: Tiejun Li: Innovator in Microparticle Formulations

Introduction

Tiejun Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of microparticle formulations for respiratory delivery.

Latest Patents

Tiejun Li holds a patent for "Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture." This innovative patent describes a process for producing microparticle formulations of a sialidase fusion protein. The method involves contacting an aqueous solution of the protein with an organic solvent, a counterion, and a scavenging agent, followed by chilling the solution. These microparticles are designed to create stable, uniform pharmaceuticals with predetermined dimensions, enhancing drug delivery to the respiratory tract.

Career Highlights

Tiejun Li is currently associated with Ansun Biopharma, Inc., where he continues to advance his research and development efforts. His work focuses on improving pharmaceutical formulations and delivery methods, which are crucial for effective treatment options.

Collaborations

Tiejun has collaborated with notable colleagues, including Michael P. Malakhov and Ron Moss, contributing to a dynamic research environment that fosters innovation and development in the pharmaceutical industry.

Conclusion

Tiejun Li's work in microparticle formulations represents a significant advancement in pharmaceutical technology, showcasing his dedication to improving drug delivery systems. His contributions are vital for the future of respiratory therapies.